Your browser doesn't support javascript.
loading
Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life.
Willemse, S B; Baak, L C; Kuiken, S D; van der Sluys Veer, A; Lettinga, K D; van der Meer, J T M; Depla, A C T M; Tuynman, H; van Nieuwkerk, C M J; Schinkel, C J; Kwa, D; Reesink, H W; van der Valk, M.
Afiliación
  • Willemse SB; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.
  • Baak LC; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis locatie Oost, Amsterdam, the Netherlands.
  • Kuiken SD; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis locatie West, Amsterdam, the Netherlands.
  • van der Sluys Veer A; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis locatie Oost, Amsterdam, the Netherlands.
  • Lettinga KD; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis locatie West, Amsterdam, the Netherlands.
  • van der Meer JT; Department of Infectious Diseases, CINIMA, Academic Medical Center, Amsterdam, the Netherlands.
  • Depla AC; Department of Gastroenterology and Hepatology, Slotervaart Ziekenhuis, Amsterdam, the Netherlands.
  • Tuynman H; Department of Gastroenterology and Hepatology, Slotervaart Ziekenhuis, Amsterdam, the Netherlands.
  • van Nieuwkerk CM; Department of Gastroenterology and Hepatology, VU Medical Center, Amsterdam, the Netherlands.
  • Schinkel CJ; Department of Medical Microbiology, Section of Clinical Virology, Academic Medical Center, Amsterdam, the Netherlands.
  • Kwa D; Department of Medical Microbiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
  • Reesink HW; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.
  • van der Valk M; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands.
J Viral Hepat ; 23(12): 950-954, 2016 12.
Article en En | MEDLINE | ID: mdl-27405785
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cirrhosis / 6_digestive_diseases Asunto principal: Antivirales / Hepacivirus / Hepatitis C Crónica / Simeprevir / Sofosbuvir / Genotipo / Cirrosis Hepática Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Viral Hepat Asunto de la revista: GASTROENTEROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cirrhosis / 6_digestive_diseases Asunto principal: Antivirales / Hepacivirus / Hepatitis C Crónica / Simeprevir / Sofosbuvir / Genotipo / Cirrosis Hepática Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Viral Hepat Asunto de la revista: GASTROENTEROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos